de Azevedo HMJ, dos Santos NWF, Lafetá ML, de Albuquerque ALP, Tanni SE, Sperandio PA, Ferreira EVM. Persistence of symptoms and return to work after hospitalization for COVID-19.
J Bras Pneumol 2022;
48:e20220194. [PMID:
36449816 PMCID:
PMC9747179 DOI:
10.36416/1806-3756/e20220194]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 10/16/2022] [Indexed: 11/12/2022] Open
Abstract
Many patients hospitalized with COVID-19 were unable to return to work or their return was delayed due to their health condition. The aim of this observational study was to evaluate the impact of moderate-to-severe and critical COVID-19 infection on persistence of symptoms and return to work after hospital discharge. In this study, two thirds of hospitalized patients with pulmonary involvement reported persistence of symptoms six months after COVID-19 infection, such as memory loss (45.5%), myalgia (43.9%), fatigue (39.4%), and dyspnea (25.8%), and 50% slowly returned to work, with repercussions due to fatigue and/or loss of energy.
Collapse